BackNatera Overview
Natera Inc

Natera Target Price

See Natera's analyst price targets ($300) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$328.18

Average Target Price

$303.097.6% downside

23 analysts in the last 4 months

High: $375 | Low: $220

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-12Stephens$3506.6% upsideOpen
2026-08-12Guggenheim$3609.7% upsideOpen
2026-08-10Morgan Stanley$3558.2% upsideOpen
2026-08-07RBC Capital$3506.6% upsideOpen
2026-08-07Robert W. BairdCatherine Ramsey Schulte$3486% upsideOpen
2026-08-07Canaccord GenuityKyle Mikson$37514.3% upsideOpen
2026-08-07Wells Fargo$28413.5% downsideOpen
2026-08-07BTIG$3202.5% downsideOpen
2026-08-07Leerink Partners$3300.6% upsideOpen
2026-08-07Barclays$3403.6% upsideOpen
2026-07-14Canaccord Genuity$3300.6% upsideOpen
2026-07-09Morgan Stanley$3105.5% downsideOpen
2026-07-06Evercore ISI$3008.6% downsideOpen
2026-06-29GuggenheimSubbu Nambi$29011.6% downsideOpen
2026-06-24BTIG$27516.2% downsideOpen
2026-06-24UBS$26020.8% downsideOpen
2026-06-23BTIG$27017.7% downsideOpen
2026-06-11RBC CapitalDan Leonard$27516.2% downsideOpen
2026-06-05Goldman SachsEvie Koslosky$24525.3% downsideOpen
2026-05-12Piper Sandler$24924.1% downsideOpen
2026-05-08Robert W. Baird$26519.3% downsideOpen
2026-05-08Evercore ISI$27017.7% downsideOpen
2026-05-08Wells FargoBrandon Couillard$22033% downsideOpen
2026-01-05Guggenheim$27017.7% downsideOpen
2025-12-22Canaccord Genuity$28513.2% downsideOpen
2025-12-15Wells Fargo$20537.5% downsideOpen
2025-12-15Barclays$27017.7% downsideOpen
2025-12-01Morgan Stanley$26519.3% downsideOpen
2025-11-18UBS$28014.7% downsideOpen
2025-10-27BNP ParibasNavann Ty$17247.6% downsideOpen
2025-09-22Wells FargoBrandon Couillard$17546.7% downsideOpen
2025-09-02RBC CapitalConor McNamara$26818.3% downsideOpen
2025-08-10Morgan StanleyPatrick Wood$19540.6% downsideOpen
2025-02-28Canaccord Genuity$19540.6% downsideOpen
2024-11-13JefferiesTycho Peterson$18244.5% downsideOpen
2024-11-13Robert W. BairdCatherine Ramsey Schulte$16051.2% downsideOpen
2024-10-29Canaccord GenuityKyle Mikson$15054.3% downsideOpen
2024-09-13Piper SandlerDave Westenberg$15054.3% downsideOpen
2024-08-27Canaccord GenuityKyle Mikson$14555.8% downsideOpen
2024-08-13Morgan StanleyTejas Savant$13259.8% downsideOpen
2024-08-09Robert W. BairdCatherine Ramsey Schulte$12063.4% downsideOpen
2024-06-25Wolfe ResearchDoug Schenkel$13558.9% downsideOpen
2024-06-03JefferiesTycho Peterson$14256.7% downsideOpen
2024-05-14Piper SandlerDavid Westenberg$12063.4% downsideOpen
2024-05-13BTIGMark Massaro$12561.9% downsideOpen
2024-05-10Robert W. BairdCatherine Ramsey Schulte$11764.3% downsideOpen
2024-04-05BernsteinEve Burstein$12063.4% downsideOpen
2022-11-14Credit Suisse$5583.2% downsideOpen
2022-08-17Piper SandlerDavid Westenberg$7078.7% downsideOpen
2022-08-05J.P. Morgan$10069.5% downsideOpen

Natera (NTRA) FAQ

The latest target price for NTRA is $300. Investors often review this figure alongside Natera's historical trend and sector peers before judging valuation or financial health.

Natera trades near $328.18 while the consensus target sits at $300 (7.6% downside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting NTRA's target price ($300), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Natera's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.